of the Federal Food, Drug, and Cosmetic Act (FDCA).* The peptide problem: Hype is outrunning the evidence BPC 157 and ipamorelin under FDA scrutiny Alex Keoskey posted on the topic LinkedIn When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions The trend of unproven peptides is spreading through influencers and RFK Jr. allies CNN The Peptide Split: How GLP 1s, Lutathera, Vosoritide, and Peptide Cancer Vaccines Are Quietly Rewriting Medicine While BPC 157, TB 500, MOTS c, and the Wellness Grift Borrow Their Halo